Brief: Senti Bio Says Highlights Preclinical Data From Logic-Gated Gene Circuit CAR-NK Cell Therapy SENTI-202
11/12/2022 14:05
Dec 11 (Reuters) - Senti Biosciences Inc SNTI.O :
* SENTI BIO HIGHLIGHTS PRECLINICAL DATA FROM LOGIC-GATED
GENE
CIRCUIT CAR-NK CELL THERAPY SENTI-202 AT ASH ANNUAL MEETING AND
INVESTOR EVENT
* SENTI-202 IS ON TRACK FOR IND FILING IN 2H 2023
Source text for Eikon: ID:nGNXqVNn6
Further company coverage: SNTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates